| Pharmaceutical Information |
| Drug Name |
Terconazole |
| Drug ID |
BADD_D02164 |
| Description |
Terconazole is an anti-fungal drug that is mainly used to treat vaginal yeast infections (or vaginal candidiasis). It is classified as a _triazole ketal derivative_.[A178096] Terconazole was initially approved by the FDA in 1987.[FDA label] This drug is available in cream and suppository forms and both have demonstrated high levels of safety, efficacy, and tolerability in clinical trials. [A178093] |
| Indications and Usage |
For the treatment of candidiasis (a yeast-like fungal infection) of the vulva and vagina. |
| Marketing Status |
approved |
| ATC Code |
G01AG02 |
| DrugBank ID |
DB00251
|
| KEGG ID |
D00888
|
| MeSH ID |
C037815
|
| PubChem ID |
441383
|
| TTD Drug ID |
D01AQT
|
| NDC Product Code |
0168-0347; 45802-717; 53002-7240; 50090-6299; 53002-8130; 0713-0552; 22568-1125; 0168-0346; 51672-1330; 63629-8837; 50090-1196; 51672-1302; 50090-0917; 59349-0011; 50090-6266; 51672-1304 |
| UNII |
0KJ2VE664U
|
| Synonyms |
terconazole | 1-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(1-methylethyl)piperazine | Fungistat | R 42470 | Terazol | Gyno-Terazol |
|
| Chemical Information |
| Molecular Formula |
C26H31Cl2N5O3 |
| CAS Registry Number |
67915-31-5 |
| SMILES |
CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
